Solid Biosciences Inc. develops therapies for neuromuscular and cardiac diseases in the United States. The company’s lead product candidate is SGT-003, which is in phase 1/2 for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback